MC38-hROR1

PDFを取得

Strain Information

表現型データ

image.png

Fig.1 hROR1 expression on in vitro cultured cells of MC38-hROR1

image.png



Fig.2 In vivo validation of MC38-hROR1 in C57BL/6 mice.C57BL/6 mice were inoculated with MC38-hROR1 subcutaneously at 3×106 cells/mouse inoculum for tumor development. The day of vaccination for mice is defined as Day 0, and tumor measurement and weight measurement begin on the 6th day after vaccination, twice a week.

image.png



Fig.3 hROR1 expression in tumors after in vivo growth of MC38-hROR1 in wild type C57BL/6 mice.The tumors were collected at day 48 post tumor cell inoculation. When the MTV reaches 1000-1500mm3, take 2 tubes from each group and send them to FACS for testing (Markers: L/D, mCD45, hROR1).


関連の系統

あなたも好きかも

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

詳細
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

詳細